Translating Insights into Gut Treg Biology to Address Immune-Related Colitis & Expand Therapeutic Applications
1:30 pm - Wednesday 24th March 2027
- Revealing how CTLA-targeting antibodies reshape Treg function in the gut and tumor microenvironment to drive immune-related colitis
- Characterizing the mechanisms by which gut-resident Tregs maintain immune homeostasis to inform the development of safer and more effective Treg-directed therapies
- Exploring emerging opportunities to manipulate Tregs across autoimmune disease, metabolic disorders, and cancer immunotherapy
Speakers:
Senior Investigator & Chief, of the Mucosal Immunology Section
National Institute of Health Science